References
- Ahmad F, Rossen L, Spencer M, Warner M, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. National Center for Health Statistics. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Published 2018.
- Kochanek K, Murphy S, Xu J, E A. Mortality in the United States, 2016. NCHS Data Brief No 293. 2017.
- Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies — tackling the Opioid-Overdose epidemic. N Engl J Med. 2014;370(22):2063–2066.
- Jaffe JH, O’Keeffe C. From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States. Drug Alcohol Depend. 2003;70(2):S3–S11.
- Jones CM, Campopiano M, Baldwin G, McCance-Katz E. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health. 2015;105(8):e55–e9.
- Rosenblatt R. a, Andrilla CHA, Catlin M, Larson EH. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med. 2015;13(1):23–26.
- Kresina TF, Litwin A, Marion I, Lubran R, Clark HW. United States Government oversight and regulation of medication assisted treatment for the treatment of opioid dependence. J Drug Policy Anal. 2009;2(1):1–23.
- Buprenorphine Waiver Management. Substance Abuse and Mental Health Service Administration. http://www.samhsa.gov/medication-assisted-treatment/buprenorphine-waiver-management. Published 2016. Accessed November 1, 2016.
- Stein BD, Sorbero M, Dick AW, Pacula RL, Burns RM, Gordon AJ. Physician capacity to treat opioid use disorder with buprenorphine-assisted treatment. JAMA 2016;316(11):1211–1212.
- Andrilla CHA, Coulthard C, Patterson DG. Prescribing practices of rural physicians waivered to prescribe buprenorphine. Am J Prev Med. 2018;54(6):S208–S214.
- Walley AY, Alperen JK, Cheng DM, et al. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. J Gen Intern Med. 2008;23(9):1393–1398.
- Thomas CP, Reif S, Haq S, et al. Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists. Psychiatr Serv. 2008;59(8):909–916.
- Netherland J, Botsko M, Egan JE, et al. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009;36(3):244–251.
- Hutchinson E, Catlin M, Andrilla CHA, Baldwin LM, Rosenblatt RA. Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med. 2014;12(2):128–133.
- Huhn AS, Dunn KE. Why aren’t physicians prescribing more buprenorphine? J Subst Abuse Treat. 2017;78:1–7.
- Kermack A, Flannery M, Tofighi B, McNeely J, Lee JD. Buprenorphine prescribing practice trends and attitudes among New York providers. J Subst Abuse Treat. 2017;74:1–6.
- Arora S, Thornton K, Jenkusky SM, Parish B, Scaletti JV. Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico. Public Health Rep. 2007;122(2_suppl):74–77.
- Zhou C, Crawford A, Serhal E, Kurdyak P, Sockalingam S. The impact of project ECHO on participant and patient outcomes: a systematic review. Acad Med J Assoc Am Med Coll. 2016;91(10):1439–1461.
- Carlin L, Zhao J, Dubin R, et al. Project ECHO telementoring intervention for managing chronic pain in primary care: insights from a qualitative study. Pain Med 2017;19(6):1–7.
- Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implementation Sci. 2009;4(1):50.
- Serhal E, Arena A, Sockalingam S, Mohri L, Crawford A. Adapting the consolidated framework for implementation research to create organizational readiness and implementation tools for project ECHO. J Contin Educ Health Prof 2018;38(0):1.
- Saldaña J. The Coding Manual for Qualitative Researchers. Thousand Oaks, CA: Sage; 2015.